Literature DB >> 16344422

Outbreak of catheter-associated Klebsiella oxytoca and Enterobacter cloacae bloodstream infections in an oncology chemotherapy center.

John T Watson1, Roderick C Jones, Alicia M Siston, Julio R Fernandez, Karen Martin, Elizabeth Beck, Steven Sokalski, Bette J Jensen, Matthew J Arduino, Arjun Srinivasan, Susan I Gerber.   

Abstract

BACKGROUND: In March 2004, the Chicago Department of Public Health was notified of a cluster of bloodstream infections with Klebsiella oxytoca and Enterobacter cloacae at a chemotherapy center. Our purpose was to identify the source of the outbreak and prevent further cases.
METHODS: The investigation included 103 oncology patients seen at an outpatient oncology chemotherapy center in Chicago during the 16 days before its closure. The outbreak investigation included case identification, retrospective cohort study, review of medical records, microbiologic testing of blood specimens, environmental cultures, and pulsed-field gel electrophoresis. The main outcome measure was infection with K oxytoca, E cloacae, or both, and the Mantel-Haenszel chi(2) test was used to assess risk of infection in relation to presence of central venous catheter.
RESULTS: Among the 103 patients, risk of infection was associated with the presence of central venous catheter (relative risk undefined, P<.001). Twenty-seven patients had blood cultures that grew K oxytoca, E cloacae, or both, and all had central venous catheters that were flushed with isotonic sodium chloride solution at the clinic from February 17 through March 3, 2004. Isolates of K oxytoca and E cloacae were matched by pulsed-field gel electrophoresis to K oxytoca and E cloacae isolates obtained from multiple predrawn syringes and from the intravenous fluid and administration set in use in the clinic at the time of its closing.
CONCLUSIONS: The injection of contaminated isotonic sodium chloride solution through the venous catheters of attendees at the clinic likely provided the opportunity for bloodstream infections in these 27 case patients. This outbreak highlights the need for continued emphasis on safe injection practices and suggests the need for guidelines and recommendations tailored to outpatient settings.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16344422     DOI: 10.1001/archinte.165.22.2639

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  14 in total

1.  Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America.

Authors:  Leonard A Mermel; Michael Allon; Emilio Bouza; Donald E Craven; Patricia Flynn; Naomi P O'Grady; Issam I Raad; Bart J A Rijnders; Robert J Sherertz; David K Warren
Journal:  Clin Infect Dis       Date:  2009-07-01       Impact factor: 9.079

2.  Outbreak of OXY-2-Producing Klebsiella oxytoca in a renal transplant unit.

Authors:  Mariela Soledad Zárate; Ana C Gales; Renata C Picão; Gervasio Soler Pujol; Alejandra Lanza; Jorgelina Smayevsky
Journal:  J Clin Microbiol       Date:  2008-04-16       Impact factor: 5.948

3.  Bloodstream Infections With a Novel Nontuberculous Mycobacterium Involving 52 Outpatient Oncology Clinic Patients-Arkansas, 2018.

Authors:  Sarah M Labuda; Kelley Garner; Michael Cima; Heather Moulton-Meissner; Alison Laufer Halpin; Nadege Charles-Toney; Peter Yu; Erin Bolton; Reid Pierce; Matthew B Crist; Danica Gomes; Paige Gable; Gillian McAllister; Adrian Lawsin; Hollis Houston; Naveen Patil; J Gary Wheeler; Robert Bradsher; Keyur Vyas; Dirk Haselow
Journal:  Clin Infect Dis       Date:  2020-10-23       Impact factor: 9.079

4.  Klebsiella oxytoca bacteremia causing septic shock in recipients of hematopoietic stem cell transplant: Two case reports.

Authors:  Khalid A Al-Anazi; Asma M Al-Jasser; Hazza A Al-Zahrani; Naem Chaudhri; Fahad I Al-Mohareb
Journal:  Cases J       Date:  2008-09-18

5.  Outbreak of bacterial meningitis among patients undergoing myelography at an outpatient radiology clinic.

Authors:  Amit S Chitnis; Alice Y Guh; Isaac Benowitz; Velusamy Srinivasan; Robert E Gertz; Patricia L Shewmaker; Bernard W Beall; Heather O'Connell; Judith Noble-Wang; Matthew F Gornet; Chris Van Beneden; Sarah L Patrick; George Turabelidze; Priti R Patel
Journal:  J Am Coll Radiol       Date:  2012-03       Impact factor: 5.532

6.  Genomic Investigation Reveals Contaminated Detergent as the Source of an Extended-Spectrum-β-Lactamase-Producing Klebsiella michiganensis Outbreak in a Neonatal Unit.

Authors:  Paul Chapman; Brian M Forde; Leah W Roberts; Haakon Bergh; Debra Vesey; Amy V Jennison; Susan Moss; David L Paterson; Scott A Beatson; Patrick N A Harris
Journal:  J Clin Microbiol       Date:  2020-04-23       Impact factor: 5.948

7.  Dissemination of clinical isolates of Klebsiella oxytoca harboring CMY-31, VIM-1, and a New OXY-2-type variant in the community.

Authors:  Athanassios Tsakris; Aggeliki Poulou; Fani Markou; Vassiliki Pitiriga; Evangelia-Theophano Piperaki; Ioulia Kristo; Spyros Pournaras
Journal:  Antimicrob Agents Chemother       Date:  2011-05-09       Impact factor: 5.191

8.  Outbreak of Tsukamurella species bloodstream infection among patients at an oncology clinic, West Virginia, 2011-2012.

Authors:  Isaac See; Duc B Nguyen; Somu Chatterjee; Thein Shwe; Melissa Scott; Sherif Ibrahim; Heather Moulton-Meissner; Steven McNulty; Judith Noble-Wang; Cindy Price; Kim Schramm; Danae Bixler; Alice Y Guh
Journal:  Infect Control Hosp Epidemiol       Date:  2014-03       Impact factor: 3.254

9.  Cost of Cancer-Related Neutropenia or Fever Hospitalizations, United States, 2012.

Authors:  Eric Tai; Gery P Guy; Angela Dunbar; Lisa C Richardson
Journal:  J Oncol Pract       Date:  2017-04-24       Impact factor: 3.840

10.  Port central venous catheters-associated bloodstream infection during outpatient-based chemotherapy.

Authors:  Davide Mauri; Sofia Roumbkou; Stella Michalopoulou; Lamprini Tsali; Anastasia Spiliopoulou; Charalampos Panou; Antonis Valachis; Angelos Panagopoulos; Nikolaos P Polyzos
Journal:  Med Oncol       Date:  2009-12-05       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.